FDA Inspection 1008821 — Eurofins Biopharma Product Testing Ireland Limited
The FDA completed an inspection of Eurofins Biopharma Product Testing Ireland Limited on Feb 24, 2017 in Dungarvan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 24, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dungarvan (Ireland)